veklury
gilead sciences (nz) - remdesivir 100mg (approx 5% overfill); - powder for injection - 100 mg - active: remdesivir 100mg (approx 5% overfill) excipient: betadex hydrochloric acid sodium hydroxide - veklury is indicated for the treatment of coronavirus disease 2019 (covid-19) in: - adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) who have pneumonia due to sars-cov-2, and who require supplemental oxygen. - adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at high risk of progressing to severe covid-19.
desrem powder
mylan pharmaceuticals (pty) ltd - powder - 100,0 mg - each vial contains remdesivir 100,0 mg
pk merz infusion 0.4mg/ml
merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - amantadine sulfate - solution for infusion - amantadine sulfate 0.4 mg/ml - anti-parkinson drugs
carvedi-denk 6,25 tablets
artesan pharma gmbh & co. kg - carvedilol - tablets - 6,25mg
merieux inactivated rabies vaccine
sanofi-aventis singapore pte. ltd. - rabies virus (wistar rabies pm/wi 38-1503-3m strain) - injection, powder, for solution - min 2.5 iu/vial
cpg 312 gel breast implant cohesive iii, low height, moderate plus profile
refacto af 250iu
wyeth farma s.a. - moroctocog alfa - powder for solution for injection - 250iu
refacto af 500iu
wyeth farma s.a. - moroctocog alfa - powder for solution for injection - 500iu